Highlights Roche Holding AG Deutsche Boerse AG

Equities

RHO

CH0012032113

Delayed Deutsche Boerse AG Other stock markets 11:41:39 2019-06-28 am EDT			5-day change	1st Jan Change
247.6 ^EUR	+0.81%		-.--%	-.--%

Jul. 05	Global markets live: Apple, Samsung, Shell, Tesla, KKR...
Jul. 05	Trending : Roche to Halt Lung-Cancer Trials After Treatment Misses Goals	DJ

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Global markets live: Apple, Samsung, Shell, Tesla, KKR...	Jul. 05
Trending : Roche to Halt Lung-Cancer Trials After Treatment Misses Goals	Jul. 05	DJ
Roche's Prefilled Syringe for Eye Drug Vabysmo Secures US FDA Nod	Jul. 05	MT
Swiss Equities Close Higher as Inflation Eases; Roche Slumps	Jul. 04	MT
Market Update-Europe closes higher on optimism about US rates	Jul. 04	RE
Dax starts trading firmer - US interest rate policy in focus	Jul. 04	RE
Roche: study in lung cancer fails and is discontinued	Jul. 04	CF
Roche to halt trial in latest setback for new cancer drug	Jul. 04	RE
Roche to Halt Lung Cancer Trial After Results Miss Goals	Jul. 04	DJ
Roche Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Small Cell Lung Cancer	Jul. 04	CI
'HB': Sanofi plans to invest billions in Frankfurt	Jul. 01	DP
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal	Jul. 01	MT
Swiss Market Index Closes Little Changed Amid Key European Inflation Data	Jun. 28	MT
Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication	Jun. 28	MT
Roche Gets EU Panel's Backing for Rare Blood Disorder Therapy	Jun. 28	MT
Roche's Vabysmo Wins EMA Panel's Backing for Retinal Vein Occlusion Indication	Jun. 28	MT
Roche's Vabysmo Gets CHMP Recommendation for Third Indication Retinal Vein Occlusion	Jun. 28	CI
Roche's Rare Blood Disorder Drug PiaSky Backed for Approval in EU	Jun. 28	MT
Chmp Recommends EU Approval of Roche?S Piasky for People with Pnh, A Rare, Life-Threatening Blood Condition	Jun. 28	CI
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	Jun. 28	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST